Resveratrol Ameliorates Experimental Alcoholic Liver Disease by Modulating Oxidative Stress

Abstract EN

The aim of this study was to investigate the hepatoprotective effects of resveratrol in alcoholic liver disease (ALD).

Alcohol was administered to healthy female rats starting from 6% (v/v) and gradually increased to 20% (v/v) by the fifth week.

After 16 weeks of intervention, liver enzymes (aspartate aminotransferase [AST] and alanine aminotransferase [ALT]) were analyzed using a chemistry analyzer, while hepatic antioxidant enzymes, oxidative stress markers, and caspase 3 activity were assessed using ELISA kits.

Furthermore, hepatic CYP2E1 protein levels and mRNA levels of antioxidant and inflammation-related genes were determined using western blotting and RT-PCR, respectively.

The results showed that resveratrol significantly attenuated alcohol-induced elevation of liver enzymes and improved hepatic antioxidant enzymes.

Resveratrol also attenuated alcohol-induced CYP2E1 increase, oxidative stress, and apoptosis (caspase 3 activity).

Moreover, genes associated with oxidative stress and inflammation were regulated by resveratrol supplementation.

Taken together, the results suggested that resveratrol alleviated ALD through regulation of oxidative stress, apoptosis, and inflammation, which was mediated at the transcriptional level.

The data suggests that resveratrol is a promising natural therapeutic agent against chronic ALD.